Outset Medical (OM) Operating Income Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Outset Medical | 90,946.35 | -286.55 Mn | 12.10 Mn | -3.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.17% |
| Dec 31, 2025 | 19.35% |
| Sep 30, 2025 | 33.67% |
| Jun 30, 2025 | 45.18% |
| Mar 31, 2025 | 55.57% |
| Dec 31, 2024 | 41.48% |
| Sep 30, 2024 | 47.55% |
| Jun 30, 2024 | 29.24% |
| Mar 31, 2024 | 15.12% |
| Dec 31, 2023 | 6.20% |
| Sep 30, 2023 | -10.87% |
| Jun 30, 2023 | 0.56% |
| Mar 31, 2023 | -19.22% |
| Dec 31, 2022 | 2.39% |
| Sep 30, 2022 | -36.04% |
| Jun 30, 2022 | -46.19% |
| Mar 31, 2022 | -22.91% |
| Dec 31, 2021 | -29.05% |
| Sep 30, 2021 | 26.01% |
| Jun 30, 2021 | -20.06% |
| Mar 31, 2021 | -46.84% |
| Dec 31, 2020 | -70.25% |
| Sep 30, 2020 | -120.78% |